Medical Device | January 01, 2026
WORK Medical scores regulatory approval for AI-powered blood analyzer
It performs white blood cell differential counts and quantifies red blood cell and platelet morphology,
It performs white blood cell differential counts and quantifies red blood cell and platelet morphology,
Marks first international filing for Evofem’s single-dose oral treatment
Performed within GENEWIZ from Azenta Life Sciences' CLIA-certified and CAP-accredited state-of-the-art clinical genomics laboratory
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
US FDA approval based on NEURO-TTRansform Phase III results
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
Tc99m tilmanocept is designed for the precise identification of lymph nodes that drain from a primary tumor, which have the highest probability of harboring cancer
Tardive dyskinesia (TD) is a movement disorder that is characterized by uncontrollable, abnormal and repetitive movements of the face, torso and/or other body parts, which may be disruptive and negatively impact patients
Guardant360 CDx is a comprehensive genomic profiling test that utilizes blood samples from patients with advanced solid cancers
The study evaluated oral semaglutide in young patients with type 2 diabetes and found it delivered a superior reduction in HbA1c
Subscribe To Our Newsletter & Stay Updated
